|
pubmed:abstractText |
Lack of basic inhaler skills by medical personnel has been documented by numerous studies. Consequently, training of patients in correct inhalational technique suffers. Newer dry powder inhalers such as Turbuhaler (budesonide, Astra USA, Westborough, MA) and Diskus (salmeterol, GlaxoSmithKline, Research Triangle Park, NC) have some advantages over conventional metereddose inhalers (MDIs) including easier technique of usage. They have been recently marketed with the hope of overcoming this problem.
|
